ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 648322 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 648322; 2) Community: the network communities that were significantly associated with the response to NSC 648322; 3) Molecule: the relationships between components within communities and NSC 648322; 4) MDR: the compounds that were significantly associated with the NSC 648322.

NSC Compound Enrichment Correlation
NSC 135037 Jatrophone 0.0114553853234976 0.77603679
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0114553853234976 0.80737246
NSC 630606 1-Piperidinecarboxylic acid, 3,5-bis(phenylmethylene)- 4-oxo-, 4-methylphenyl ester 0.0114553853234976 0.45811139
NSC 644651 Null 0.0114553853234976 0.55973396
NSC 163062 TRIPTOLIDE 0.0119653763676521 0.25545184
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.0119653763676521 0.42079137
NSC 281613 Ethanol, 2,2'-[[4-[[[3-chloro-4-(2-phenyl-4-thiazolyl)phenyl]imino]methyl]-3-methylphenyl]imino]bis-, dimethanesulfonate (ester) 0.0119653763676521 0.13486726
NSC 321239 Mercury, (2-hydroxy-5-nitrophenyl)(6-thioguanosinato-N(7),S(6))- 0.0119653763676521 0.3502767
NSC 373355 Saframycin R 0.0119653763676521 0.52823748
NSC 48229 Null 0.0119653763676521 -0.23920194
Total:97  Current:33    [First] [Prev] [Next] [Last]